Form 6-K - Report of foreign issuer [Rules 13a-16 and 15d-16]:
SEC Accession No. 0001628280-25-025725
Filing Date
2025-05-15
Accepted
2025-05-15 13:04:16
Documents
4
Period of Report
2025-05-15

Document Format Files

Seq Description Document Type Size
1 6-K a6-kformmanagerstransactio.htm 6-K 11212
2 EX-99.1 AMF DECLARATION exhibit991may152025.htm EX-99.1 3326
3 exhibit991may152025001.jpg GRAPHIC 126684
4 exhibit991may152025002.jpg GRAPHIC 55904
  Complete submission text file 0001628280-25-025725.txt   267114
Mailing Address 60 RUE DE WATTIGNIES PARIS I0 75012
Business Address 60 RUE DE WATTIGNIES PARIS I0 75012 33140260470
Nanobiotix S.A. (Filer) CIK: 0001760854 (see all company filings)

EIN.: 000000000 | State of Incorp.: I0 | Fiscal Year End: 1231
Type: 6-K | Act: 34 | File No.: 001-39777 | Film No.: 25950885
SIC: 2834 Pharmaceutical Preparations
(CF Office: 03 Life Sciences)